These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 27158139)

  • 41. Fragment merging approach for the design of thiazole/thiazolidine clubbed pyrazoline derivatives as anti-inflammatory agents: Synthesis, biopharmacological evaluation and molecular modeling studies.
    Elgohary MK; Abd El Hadi SR; Abo-Ashour MF; Abo-El Fetoh ME; Afify H; Abdel-Aziz HA; Abou-Seri SM
    Bioorg Chem; 2023 Oct; 139():106724. PubMed ID: 37451146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,3,5-triarylpyrazoline and 1,5-diarylpyrazole derivatives as selective COX-2 inhibitors.
    Abdellatif KRA; Abdelall EKA; Fadaly WAA; Kamel GM
    Bioorg Med Chem Lett; 2016 Jan; 26(2):406-412. PubMed ID: 26691756
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis, molecular modelling and biological evaluation of novel 3-(2-naphthyl)-1-phenyl-1H-pyrazole derivatives as potent antioxidants and 15-Lipoxygenase inhibitors.
    Ali SA; Awad SM; Said AM; Mahgoub S; Taha H; Ahmed NM
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):847-863. PubMed ID: 32216479
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study.
    Lamie PF; Ali WAM; Bazgier V; Rárová L
    Eur J Med Chem; 2016 Nov; 123():803-813. PubMed ID: 27541263
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Further insight into the dual COX-2 and 15-LOX anti-inflammatory activity of 1,3,4-thiadiazole-thiazolidinone hybrids: The contribution of the substituents at 5th positions is size dependent.
    Omar YM; Abdel-Moty SG; Abdu-Allah HHM
    Bioorg Chem; 2020 Apr; 97():103657. PubMed ID: 32086052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition.
    Ghanim AM; Rezq S; Ibrahim TS; Romero DG; Kothayer H
    Eur J Med Chem; 2021 Jul; 219():113457. PubMed ID: 33892270
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis, anti-inflammatory, cyclooxygenases inhibitions assays and histopathological study of poly-substituted 1,3,5-triazines: Confirmation of regiospecific pyrazole cyclization by HMBC.
    Elshemy HAH; Abdelall EKA; Azouz AA; Moawad A; Ali WAM; Safwat NM
    Eur J Med Chem; 2017 Feb; 127():10-21. PubMed ID: 28038322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design, synthesis, and biological evaluation of new pyrazoloquinazoline derivatives as dual COX-2/5-LOX inhibitors.
    Shaaban MA; Kamal AM; Faggal SI; Farag NA; Aborehab NM; Elsahar AE; Mohamed KO
    Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000027. PubMed ID: 32696514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel tetrazole-based selective COX-2 inhibitors: Design, synthesis, anti-inflammatory activity, evaluation of PGE
    Labib MB; Fayez AM; El-Nahass ES; Awadallah M; Halim PA
    Bioorg Chem; 2020 Nov; 104():104308. PubMed ID: 33011534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis of new pyrazoles and pyrozolo [3,4-b] pyridines as anti-inflammatory agents by inhibition of COX-2 enzyme.
    Mohamed LW; Shaaban MA; Zaher AF; Alhamaky SM; Elsahar AM
    Bioorg Chem; 2019 Mar; 83():47-54. PubMed ID: 30342385
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 1,3,4-Trisubstituted pyrazole analogues as promising anti-inflammatory agents.
    Alegaon SG; Alagawadi KR; Garg MK; Dushyant K; Vinod D
    Bioorg Chem; 2014 Jun; 54():51-9. PubMed ID: 24793214
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tailored quinoline hybrids as promising COX-2/15-LOX dual inhibitors endowed with diverse safety profile: Design, synthesis, SAR, and histopathological study.
    Hegazy ME; Taher ES; Ghiaty AH; Bayoumi AH
    Bioorg Chem; 2024 Apr; 145():107244. PubMed ID: 38428284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Towards safer anti-inflammatory therapy: synthesis of new thymol-pyrazole hybrids as dual COX-2/5-LOX inhibitors.
    El-Miligy MMM; Al-Kubeisi AK; Bekhit MG; El-Zemity SR; Nassra RA; Hazzaa AA
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):294-308. PubMed ID: 36408833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and development of thiazole leads as COX-2/5-LOX inhibitors through in-vitro and in-vivo biological evaluation for anti-inflammatory activity.
    Jacob P J; Manju SL
    Bioorg Chem; 2020 Jul; 100():103882. PubMed ID: 32361295
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis, biological evaluation, docking study and ulcerogenicity profiling of some novel quinoline-2-carboxamides as dual COXs/LOX inhibitors endowed with anti-inflammatory activity.
    Abdelrahman MH; Youssif BGM; Abdelgawad MA; Abdelazeem AH; Ibrahim HM; Moustafa AEGA; Treamblu L; Bukhari SNA
    Eur J Med Chem; 2017 Feb; 127():972-985. PubMed ID: 27837994
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, synthesis and biological screening of some novel celecoxib and etoricoxib analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
    Alsayed SS; Elshemy HA; Abdelgawad MA; Abdel-Latif MS; Abdellatif KR
    Bioorg Chem; 2017 Feb; 70():173-183. PubMed ID: 28057325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation.
    Ahmed EM; Hassan MSA; El-Malah AA; Kassab AE
    Bioorg Chem; 2020 Jan; 95():103497. PubMed ID: 31838289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.
    Abdellatif KRA; Fadaly WAA; Kamel GM; Elshaier YAMM; El-Magd MA
    Bioorg Chem; 2019 Feb; 82():86-99. PubMed ID: 30278282
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.
    Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H
    Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tailoring the substitution pattern of Pyrrolidine-2,5-dione for discovery of new structural template for dual COX/LOX inhibition.
    Sadiq A; Mahnashi MH; Alyami BA; Alqahtani YS; Alqarni AO; Rashid U
    Bioorg Chem; 2021 Jul; 112():104969. PubMed ID: 34023639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.